SUBSCRIBE
SUBSCRIBE
News   Deals

Ipsen Aims To Raise €400 Million In IPO

November 23, 2005 | 
1 min read
Ipsen, the French pharmaceuticals company, yesterday unveiled plans to raise about €400m ($470m) in an initial public offering, which would reduce the stake of the family of founder Henri Beaufour and raise funds for research.
IPO Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Odyssey tests IPO waters anew after quitting quest last year
April 20, 2026
 · 
10 min read
 · 
Tristan Manalac
Reaching an agreement. Businessmen shake hands and make a deal. vector
Mergers & acquisitions
UCB elevates epilepsy expertise with up to $1.15B Neurona takeover
April 20, 2026
 · 
2 min read
 · 
Tristan Manalac
Concept of money prize. Vector illustration. Halftone hand holds bouquet of money flowers. Gift prize, donation, earnings, bonus or cashback concept. Retro poster or banner. Creative trend collage.
IPO
UPDATE: Kailera breaks biotech IPO record with $625M debut
April 17, 2026
 · 
4 min read
 · 
Tristan Manalac
Insights
Funding the future of European biotech
April 16, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker